A novel surface marker helps scientists 'fish out' mammary gland stem cells

April 11, 2013, Cold Spring Harbor Laboratory

Stem cells are different from all other cells in our body because they retain the remarkable genetic plasticity to self-renew indefinitely as well as develop into cell types with more specialized functions. However, this remarkable self-renewal capacity comes with a price, as stem cells can become seeds of cancer. Identifying genetic programs that maintain self-renewing capabilities therefore is a vital step in understanding the errors that derail a normal stem cell, sending it on a path to become a cancer stem cell.

Isolating cells from various other cell types is very much like fishing—you need a good "hook" that can recognize a specific protein marker on the surface of a cell, in order to pull that cell out. Until now, isolating pure stem cells (MaSCs), which are important in mammary gland development as well as breast , has posed a challenge. MaSCs are scarce and share common cell-surface markers with other cells. In a paper published today in Proceedings of the National Academy of Sciences, scientists in the laboratory of Professor Gregory Hannon at Cold Spring Harbor Laboratory (CSHL) used a mouse model to identify a novel cell surface marker on MaSCs. Using that marker, the team was able to assemble a sample of MaSCs of unprecedented purity.

"We are describing a marker called Cd1d," says CSHL research investigator Camila Dos Santos, Ph.D., the paper's first author. The marker, also present at the surface of specialized , is expressed on the surface of a defined population of mammary cells in both mice and humans.

The team took advantage of the fact that MaSCs divide much slower than other cells. They utilized a mouse strain, which expresses a , or GFP, in a subtype of epithelial cells, including MaSCs. The trick is that this gene can be turned off by feeding mice a chemical called doxycycline. "The beauty of [this model] is that by stopping GFP expression, you can directly measure the number of cell divisions that have happened since GFP was turned off," Dos Santos explains. "The cells that divide the least will carry GFP the longest and are the ones we characterized."

Using this approach, Dos Santos and her colleagues were able to select stem cells in the mammary glands to examine their gene expression signature. They confirmed that a purification method that used Cd1d, in combination with other known markers, greatly enhanced purity compared to other methods, including those previously published.

"With this advancement, we are now able to profile normal and cancer at a very high degree of purity , and perhaps point out which genes should be investigated as the next drug targets," says Professor Hannon, who is also an Investigator of the Howard Hughes Medical Institute.

Explore further: Exploring the relation between stem cells and tumor growth

More information: "Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells" appeared online in Proceedings of the National Academy of Sciences. The authors are: Camila O. dos Santos, Clare Rebbeck, Elena Rozhkova, Amy Valentine, Abigail Samuels, Lolahon Kadiri, Pavel Osten, Elena Y. Harris, Phillip J. Urei, Andrew D. Smith, and Gregory J. Hannon. DOI:10.1073/pnas.1303919110

Related Stories

Exploring the relation between stem cells and tumor growth

July 16, 2012
An EU research project has shed light on the tumor-growth role of a key-signalling pathway in mammary gland stem cells.

Scientists discover marker to identify, attack breast cancer stem cells

May 16, 2012
Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug, researchers at The University of ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.